Back to Trial Categories

Cancer Trials

Disease: Bladder
A Pilot Study of Neoadjuvant Dasatinib Followed by Radical Cystectomy for Transitional Cell Carcinoma of the Bladder - GU07-122
Status: Open to Accrual 08-21-2008 at Limited Institutions Only - 15 of 25 Patients Accrued
More Details
Disease: Bladder
Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) - GU07-123
Status: Original Open to IU only as of 12/19/2008; Accrual 7 of 46
More Details
Disease: Bladder
Phase II Trial of Docetaxel plus ASA404 as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma - GU09-144
Status: SUSPENDED to further accrual 04/08/2010; Open to Accrual 03/31/2010
More Details